2020
DOI: 10.1016/j.envint.2020.106120
|View full text |Cite
|
Sign up to set email alerts
|

Profiles of urinary neonicotinoids and dialkylphosphates in populations in nine countries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
23
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 64 publications
(34 citation statements)
references
References 43 publications
3
23
0
Order By: Relevance
“…Wang et al (2020) reported a low detection frequency of 38% for ACE in tandem with 96.6% detection frequency for dm‐ACE in a Chinese population. Li and Kannan (2020) and Ospina et al (2019) reported high detection rates for dm‐ACE in human subjects from various countries across the world, but their study did not detect ACE in any of their target population. Meanwhile, the detection frequency and median concentrations of ACE recorded within the present study population (2.67% and <LOQ, respectively) were far lower than what was previously reported for a Japanese population (detection frequency 56%, median concentration 0.02 µg/L [Ueyama et al 2014]) and a Chinese population (detection frequency 96%, median concentration 0.014 µg/L [Zhang et al 2019]).…”
Section: Resultsmentioning
confidence: 90%
See 2 more Smart Citations
“…Wang et al (2020) reported a low detection frequency of 38% for ACE in tandem with 96.6% detection frequency for dm‐ACE in a Chinese population. Li and Kannan (2020) and Ospina et al (2019) reported high detection rates for dm‐ACE in human subjects from various countries across the world, but their study did not detect ACE in any of their target population. Meanwhile, the detection frequency and median concentrations of ACE recorded within the present study population (2.67% and <LOQ, respectively) were far lower than what was previously reported for a Japanese population (detection frequency 56%, median concentration 0.02 µg/L [Ueyama et al 2014]) and a Chinese population (detection frequency 96%, median concentration 0.014 µg/L [Zhang et al 2019]).…”
Section: Resultsmentioning
confidence: 90%
“…Imidacloprid was predominantly detected in 70.7% of the present study population, with a mean concentration of 2.794 ± 19.01 µg/L (1.09 ± 4.90 µg/g Cre) and a range of <LOQ to 165.01 µg/L (<LOQ–42.00 µg/g Cre). Several biomonitoring studies have similarly reported a high detection frequency of >70% for IMI in various human populations across the world (Ueyama et al 2015; Honda et al 2019; Zhang et al 2019; Li and Kannan 2020; Wang et al 2020). In the present study, the maximum concentration of IMI recorded among the study population (165.01 µg/L, 42.00 µg/g Cre) far exceeded those recorded for all the other detected NNIs.…”
Section: Resultsmentioning
confidence: 98%
See 1 more Smart Citation
“…For mice, treated with NOAEL levels of Imida and Aceta (10 mg/kg), the brain levels were around 3–6 ppm, and plasma concentrations were in a similar range (15–30 µM) (Ford and Casida 2006 ). Human data are mostly available for urinary metabolites used for biomonitoring, and the concentrations were maximally in the low nM range (Zhang et al 2019 ; Li et al 2020 ; Li and Kannan 2020 ). Due to the lack of more direct data, we built physiology-based toxicokinetic (PBTK) models to predict plasma and brain concentrations (Table S11).…”
Section: Resultsmentioning
confidence: 99%
“…To evaluate OPP exposure, urinary concentrations of common OPP metabolites, i.e., dialkylphosphates (DAPs) including dimethylphosphate (DMP), diethylphosphate (DEP), dimethylthiophosphate (DMTP), diethylthiophosphate (DETP), dimethylditiophosphate (DMDTP) and diethyldithiophosphate (DEDTP), are usually used as biomarkers in cohort studies [ 15 ]. OPPs with mono-thio or di-thio moieties have been reported to be metabolised by three kinds of DAPs, i.e., dialkyl, dialkylthio and dialkyidithio phosphates [ 16 ].…”
Section: Introductionmentioning
confidence: 99%